APA (7th ed.) Citation

Safavi, F., Nourbakhsh, B., & Azimi, A. R. (2020). B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran. Multiple sclerosis and related disorders, 43, 102195. https://doi.org/10.1016/j.msard.2020.102195

Chicago Style (17th ed.) Citation

Safavi, Farinaz, Bardia Nourbakhsh, and Amir Reza Azimi. "B-cell Depleting Therapies May Affect Susceptibility to Acute Respiratory Illness Among Patients with Multiple Sclerosis During the Early COVID-19 Epidemic in Iran." Multiple Sclerosis and Related Disorders 43 (2020): 102195. https://doi.org/10.1016/j.msard.2020.102195.

MLA (9th ed.) Citation

Safavi, Farinaz, et al. "B-cell Depleting Therapies May Affect Susceptibility to Acute Respiratory Illness Among Patients with Multiple Sclerosis During the Early COVID-19 Epidemic in Iran." Multiple Sclerosis and Related Disorders, vol. 43, 2020, p. 102195, https://doi.org/10.1016/j.msard.2020.102195.